Wang et al. (32) divided 80 PD patients into treatment groups and found that combining HBOT with standard dopamine therapy significantly improved Unified Parkinson’s Disease Rating Scale (UPDRS) and Parkinson’s Disease Sleep Scale (PDSS) scores, reduced serum MDA levels, and increased serum SOD and GSH-Px levels. Here, SOD1 is linked to Parkinson disease.